Assessing the Impact of Lithium Chloride on the Expression of P-Glycoprotein at the Blood-Brain Barrier. (Q48354738)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28093288%20AND%20SRC:MED&resulttype=core&format=json

10 April 2020

title

Assessing the Impact of Lithium Chloride on the Expression of P-Glycoprotein at the Blood-Brain Barrier (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28093288%20AND%20SRC:MED&resulttype=core&format=json

10 April 2020

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28093288%20AND%20SRC:MED&resulttype=core&format=json

10 April 2020

author name string

Stephanie A Newman

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28093288%20AND%20SRC:MED&resulttype=core&format=json

10 April 2020

Jennifer L Short

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28093288%20AND%20SRC:MED&resulttype=core&format=json

10 April 2020

Joseph A Nicolazzo

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28093288%20AND%20SRC:MED&resulttype=core&format=json

10 April 2020

language of work or name

English

0 references

publication date

16 January 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28093288%20AND%20SRC:MED&resulttype=core&format=json

Journal of Pharmaceutical Sciences

10 April 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28093288%20AND%20SRC:MED&resulttype=core&format=json

10 April 2020

volume

106

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28093288%20AND%20SRC:MED&resulttype=core&format=json

10 April 2020

issue

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28093288%20AND%20SRC:MED&resulttype=core&format=json

10 April 2020

page(s)

2625-2631

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28093288%20AND%20SRC:MED&resulttype=core&format=json

Alzheimer's disease: genes, proteins, and therapy

10 April 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.XPHS.2017.01.013

Alzheimer's disease: the amyloid cascade hypothesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.XPHS.2017.01.013

Decreased clearance of CNS beta-amyloid in Alzheimer's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.XPHS.2017.01.013

Alzheimer's disease beta-amyloid peptide is increased in mice deficient in endothelin-converting enzyme

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.XPHS.2017.01.013

Alzheimer's disease, normal-pressure hydrocephalus, and senescent changes in CSF circulatory physiology: a hypothesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.XPHS.2017.01.013

Perivascular drainage of amyloid-beta peptides from the brain and its failure in cerebral amyloid angiopathy and Alzheimer's disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.XPHS.2017.01.013

Clearance of Alzheimer's amyloid-ss(1-40) peptide from brain by LDL receptor-related protein-1 at the blood-brain barrier

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.XPHS.2017.01.013

LRP/amyloid beta-peptide interaction mediates differential brain efflux of Abeta isoforms.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.XPHS.2017.01.013

P-glycoprotein deficiency at the blood-brain barrier increases amyloid-beta deposition in an Alzheimer disease mouse model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.XPHS.2017.01.013

Neurovascular mechanisms of Alzheimer's neurodegeneration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.XPHS.2017.01.013

Low‐density lipoprotein receptor‐related protein‐1: a serial clearance homeostatic mechanism controlling Alzheimer’s amyloid β‐peptide elimination from the brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.XPHS.2017.01.013

Efflux of human and mouse amyloid β proteins 1–40 and 1–42 from brain: impairment in a mouse model of alzheimer's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.XPHS.2017.01.013

Multidrug-resistance gene (P-glycoprotein) is expressed by endothelial cells at blood-brain barrier sites

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.XPHS.2017.01.013

P-glycoprotein is strongly expressed in the luminal membranes of the endothelium of blood vessels in the brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.XPHS.2017.01.013

P-Glycoprotein, a gatekeeper in the blood-brain barrier

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.XPHS.2017.01.013

ABC efflux transporters in brain vasculature of Alzheimer's subjects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.XPHS.2017.01.013

An investigation into the role of P-glycoprotein in Alzheimer's disease lesion pathogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.XPHS.2017.01.013

Altered brain uptake of therapeutics in a triple transgenic mouse model of Alzheimer's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.XPHS.2017.01.013

Aβ1-42 reduces P-glycoprotein in the blood-brain barrier through RAGE-NF-κB signaling

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.XPHS.2017.01.013

Restoring blood-brain barrier P-glycoprotein reduces brain amyloid-beta in a mouse model of Alzheimer's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.XPHS.2017.01.013

1α,25-Dihydroxyvitamin D3 reduces cerebral amyloid-β accumulation and improves cognition in mouse models of Alzheimer's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.XPHS.2017.01.013

1α,25-Dihydroxyvitamin D3-liganded vitamin D receptor increases expression and transport activity of P-glycoprotein in isolated rat brain capillaries and human and rat brain microvessel endothelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.XPHS.2017.01.013

Lithium and risk for Alzheimer's disease in elderly patients with bipolar disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.XPHS.2017.01.013

Disease-modifying properties of long-term lithium treatment for amnestic mild cognitive impairment: randomised controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.XPHS.2017.01.013

The GSK3 hypothesis of Alzheimer's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.XPHS.2017.01.013

GSK-3alpha regulates production of Alzheimer's disease amyloid-beta peptides

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.XPHS.2017.01.013

Lithium reduces tau phosphorylation: effects in living cells and in neurons at therapeutic concentrations.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.XPHS.2017.01.013

Inhibition of glycogen synthase kinase-3 by lithium correlates with reduced tauopathy and degeneration in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.XPHS.2017.01.013

Age as a factor affecting lithium therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.XPHS.2017.01.013

Fatty Acid-Binding Protein 5 at the Blood-Brain Barrier Regulates Endogenous Brain Docosahexaenoic Acid Levels and Cognitive Function.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.XPHS.2017.01.013

Blood-brain barrier-specific properties of a human adult brain endothelial cell line

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.XPHS.2017.01.013

Regulation of P-glycoprotein by orphan nuclear receptors in human brain microvessel endothelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.XPHS.2017.01.013

Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.XPHS.2017.01.013

Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.XPHS.2017.01.013

Drug-induced trafficking of p-glycoprotein in human brain capillary endothelial cells as demonstrated by exposure to mitomycin C

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.XPHS.2017.01.013

Exposure to antiepileptic drugs does not alter the functionality of P-glycoprotein in brain capillary endothelial and kidney cell lines.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.XPHS.2017.01.013

Regulation of BCRP (ABCG2) and P-glycoprotein (ABCB1) by cytokines in a model of the human blood-brain barrier

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.XPHS.2017.01.013

Characterization of rhodamine-123 as a tracer dye for use in in vitro drug transport assays

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.XPHS.2017.01.013

Aβ40 Reduces P-Glycoprotein at the Blood-Brain Barrier through the Ubiquitin-Proteasome Pathway.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.XPHS.2017.01.013

Beta amyloid effects on expression of multidrug efflux transporters in brain endothelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.XPHS.2017.01.013

Wnt activation of immortalized brain endothelial cells as a tool for generating a standardized model of the blood brain barrier in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.XPHS.2017.01.013

Decreased blood–brain Barrier Expression of P-glycoprotein in Alzheimer‘s Disease: Impact on Pathogenesis and Brain Access of Therapeutic Agents

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.XPHS.2017.01.013

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.XPHS.2017.01.013

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28093288%20AND%20SRC:MED&resulttype=core&format=json

10 April 2020

1 reference